Fibrolamellar patient participation requested in National Cancer Institute (NCI) study

Fibrolamellar patients are invited and encouraged to participate in the Natural History Study of Rare Solid Tumors, currently underway at the National Cancer Institute (NCI) in Bethesda, Maryland. The purpose of this study is to better understand how rare solid tumors develop and grow. Natural history studies like this will help researchers learn more about …

Read moreFibrolamellar patient participation requested in National Cancer Institute (NCI) study